2020
DOI: 10.1016/j.jaci.2019.09.027
|View full text |Cite
|
Sign up to set email alerts
|

Food protein–induced enterocolitis and alpha-1-antitrypsin deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 8 publications
(9 reference statements)
0
5
0
Order By: Relevance
“…Majamaa et al [48] observed that an increased concentration of fecal α1-antitrypsin is associated with CMA in infants with atopic eczema. However, other authors analyzed α 1-antitrypsin levels along with a panel of different markers in patients with GIT disorders and found no significant differences for this protein [32,49]. In relation to CMA, there are scarce data, and the results are contradictory.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Majamaa et al [48] observed that an increased concentration of fecal α1-antitrypsin is associated with CMA in infants with atopic eczema. However, other authors analyzed α 1-antitrypsin levels along with a panel of different markers in patients with GIT disorders and found no significant differences for this protein [32,49]. In relation to CMA, there are scarce data, and the results are contradictory.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, the use of fecal biomarkers for the diagnosis of CMA has recently been reviewed [27]. The proteins most studied as potential fecal biomarkers of this disease are fecal calprotectin, α-1 antitrypsin, and lactoferrin [28][29][30][31][32]. α1-Antitrypsin is a nondietary serum protein synthesized in the liver [33].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, α-1 antitrypsin is an inhibitor of serine proteases present in serum which is synthesized in the liver [85]. It can be measured to assess the excessive GI protein losses in patients with protein-losing enteropathy (PLE) [86,87]. It should be noted that PLE must not be confused with α-1 antitrypsin deficiency, a separate condition, as has sometimes been reported in the literature [87].…”
Section: Fecal Biomarkers Protein Analysismentioning
confidence: 99%
“…It can be measured to assess the excessive GI protein losses in patients with protein-losing enteropathy (PLE) [86,87]. It should be noted that PLE must not be confused with α-1 antitrypsin deficiency, a separate condition, as has sometimes been reported in the literature [87]. In the case of CMA, there is very little data: to the best of our knowledge, only one paper reports its measurement in a study of CMA, alongside a panel of other markers, and did not find significant differences for this protein [88].…”
Section: Fecal Biomarkers Protein Analysismentioning
confidence: 99%